ArticleOne health (Amsterdam, Netherlands)2025
Molecular detection and characterization of human bocavirus in environmental waters in Thailand from 2020 to 2022.
Article in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- First Report of Human Bocavirus Genotypes 1-3 in Argentine Wastewater and Insights into Community Circulation.Food and environmental virology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human bocavirus (HBoV) is a globally recognized pathogen associated with respiratory and gastrointestinal infections in infants and young children. Its detection in both clinical and environmental water samples has raised concerns about potential waterborne transmission. This study investigated the prevalence and genetic diversity of HBoV in environmental water sources in Chang Mai, Thailand, from July 2020 to December 2022. A total of 600 water samples from various environmental sources were analyzed using PCR assay. Nucleotide sequencing and phylogenetic analysis were performed to identify HBoV genotypes and assess their genetic characteristics. HBoV was detected in 32 of 600 samples (5.3 %), representing a notable decline in the detection rates during the COVID-19 pandemic. Among the sample types, wastewater showed highest detection rate (23.3 %), followed by irrigation water (1.2 %), and river water (0.8 %). No HBoV was detected in environmental reservoir water samples. All four known HBoV genotypes (HBoV1-HBoV4) were identified, with HBoV2 being the most prevalent genotype (19 strains; 59.4 %), followed by HBoV3 (6 strains; 18.8 %), HBoV1 (5 strains; 15.6 %), and HBoV4 (2 strains; 6.2 %). No clear seasonal pattern of HBoV contamination was observed. Phylogenetic analysis revealed a close genetic relationship between environmental and human-associated HBoV strains, suggesting an interactive transmission of HBoV between human and the environment. This study highlights the prevalence and genetic diversity of HBoV in environmental waters during the COVID-19 pandemic and underscores the need for continued surveillance to a better understanding its environmental dynamics and potential public health implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.